Recursion Pharmaceuticals, Inc. (RXRX)
3.32
0.00 (0.00%)
USD |
NASDAQ |
Jun 08, 16:00
3.32
0.00 (0.00%)
After-Hours: 05:17
Recursion Pharmaceuticals Shareholders Equity (Quarterly) : 1.025B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Stoke Therapeutics, Inc. | 394.88M |
| Agenus, Inc. | -221.22M |
| Amgen, Inc. | 9.19B |
| BioCryst Pharmaceuticals, Inc. | -553.84M |
| Imunon, Inc. | 3.360M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.340B |
| Total Liabilities (Quarterly) | 314.75M |
| Debt to Equity Ratio | 0.0706 |
| Current Ratio | 5.471 |
| Net Debt Paydown Yield | 0.44% |